BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17510952)

  • 21. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
    Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
    Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intergenic variants may predispose to major depression disorder through regulation of long non-coding RNA expression.
    Ye N; Rao S; Du T; Hu H; Liu Z; Shen Y; Xu Q
    Gene; 2017 Feb; 601():21-26. PubMed ID: 27940106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors.
    Panagopoulos I; Brandal P; Gorunova L; Bjerkehagen B; Heim S
    Int J Oncol; 2014 May; 44(5):1425-32. PubMed ID: 24604026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens.
    Alexander B; Warner-Schmidt J; Eriksson T; Tamminga C; Arango-Lievano M; Ghose S; Vernov M; Stavarache M; Musatov S; Flajolet M; Svenningsson P; Greengard P; Kaplitt MG
    Sci Transl Med; 2010 Oct; 2(54):54ra76. PubMed ID: 20962330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replacement of homologous mouse DNA sequence with pathogenic 6-base human CREB1 promoter sequence creates murine model of major depressive disorder.
    Zubenko GS; Hughes HB
    Am J Med Genet B Neuropsychiatr Genet; 2011 Jul; 156B(5):517-31. PubMed ID: 21598377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does refining the phenotype improve replication rates? A review and replication of candidate gene studies on Major Depressive Disorder and Chronic Major Depressive Disorder.
    Luo X; Stavrakakis N; Penninx BW; Bosker FJ; Nolen WA; Boomsma DI; de Geus EJ; Smit JH; Snieder H; Nolte IM; Hartman CA
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):215-36. PubMed ID: 26566975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p11 and gene therapy for severe psychiatric disorders: a practical goal?
    Chen G; Twyman R; Manji HK
    Sci Transl Med; 2010 Oct; 2(54):54ps51. PubMed ID: 20962329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of purinergic receptor P2RX7 gene polymorphisms with depression symptoms.
    Vereczkei A; Abdul-Rahman O; Halmai Z; Nagy G; Szekely A; Somogyi A; Faludi G; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():207-216. PubMed ID: 30664971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.
    Kitzlerová E; Fišar Z; Lelková P; Jirák R; Zvěřová M; Hroudová J; Manukyan A; Martásek P; Raboch J
    Med Sci Monit; 2018 Apr; 24():2599-2619. PubMed ID: 29703883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FKBP5 polymorphism is associated with major depression but not with bipolar disorder.
    Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Narozna B; Rajewska-Rager A; Wilkosc M; Zaremba D; Maciukiewicz M; Twarowska-Hauser J
    J Affect Disord; 2014 Aug; 164():33-7. PubMed ID: 24856550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common variants in FKBP5 gene and major depressive disorder (MDD) susceptibility: a comprehensive meta-analysis.
    Rao S; Yao Y; Ryan J; Li T; Wang D; Zheng C; Xu Y; Xu Q
    Sci Rep; 2016 Sep; 6():32687. PubMed ID: 27601205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.
    Inkster B; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM
    Arch Gen Psychiatry; 2009 Jul; 66(7):721-8. PubMed ID: 19581563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder.
    Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Rajewska-Rager A; Dmitrzak-Weglarz M; Wilkosc M; Skibinska M; Hauser J
    J Affect Disord; 2011 Nov; 134(1-3):138-44. PubMed ID: 21764460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder.
    Van Den Eede F; Venken T; Del-Favero J; Norrback KF; Souery D; Nilsson LG; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Mendlewicz J; Adolfsson R; Van Broeckhoven C; Claes SJ
    Psychiatry Res; 2007 Sep; 153(1):17-25. PubMed ID: 17599466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain.
    Milosevic A; Liebmann T; Knudsen M; Schintu N; Svenningsson P; Greengard P
    J Comp Neurol; 2017 Mar; 525(4):955-975. PubMed ID: 27616678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple functions of S100A10, an important cancer promoter.
    Saiki Y; Horii A
    Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility.
    Soria V; Martínez-Amorós E; Escaramís G; Valero J; Crespo JM; Gutiérrez-Zotes A; Bayés M; Martorell L; Vilella E; Estivill X; Menchón JM; Gratacòs M; Urretavizcaya M
    J Pineal Res; 2010 Aug; 49(1):35-44. PubMed ID: 20459461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
    Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
    J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The P11, tPA/plasminogen system and brain-derived neurotrophic factor: Implications for the pathogenesis of major depression and the therapeutic mechanism of antidepressants.
    Tsai SJ
    Med Hypotheses; 2007; 68(1):180-3. PubMed ID: 16890384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid-induced p11 over-expression and chromatin remodeling: a novel molecular mechanism of traumatic stress?
    Zhang L; Li H; Hu X; Li XX; Smerin S; Ursano R
    Med Hypotheses; 2011 Jun; 76(6):774-7. PubMed ID: 21367534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.